Sai Parenteral’s IPO GMP: Day 1 IPO Live Updates

The Sai Parenteral’s IPO GMP is ₹0 as of 24th March 2026. It is an IPO bookbuild issue of ₹408.79 crores. This is an entirely fresh Issue of 0.73 crore shares and an offer for sale of 0.32 crore. The issue will be listed on BSE and NSE on its tentative listing date, 2nd April 2026. The face value of Sai Parenteral’s IPO shares is ₹10 per share, and the IPO price band is ₹372 to ₹212 per share. Retail investors can bid for a minimum of 1 lot of 38 shares worth ₹14,896. 

Sai Parenteral’s IPO Grey Market Premium

As of 24th March 2025, the GMP for the Sai Parenteral’s IPO stands at ₹0.00 per share. Thus, the estimated listing price would be ₹392.00. This indicates that the estimated listing gain in this IPO could be 0.00%. However, GMP details are subject to change in response to market conditions and fluctuations. Explore the table for GMP updates on the Sai Parenteral’s IPO.

Click & Sign Up to Get Latest Updates on Sai Parenteral’s IPO

Sai Parenteral’s IPO Details

Explanation

Sai Parenteral’s IPO: Sai Parenteral’s IPO Limited has declared an issue price band of ₹372 to ₹392 per share. With this IPO, the company allows retail investors to bid for at least 1 lot of 38 shares, each worth ₹14,896. The face value of Sai Parenteral’s IPO Limited shares is ₹10 per share. The shares of Sai Parenteral’s IPO Limited will be listed on BSE and NSE on its tentative listing day, 2nd April 2026. Scroll down to check GMP updates and Sai Parenteral’s IPO reviews. 

Objectives of the Sai Parenteral’s IPO

The primary aim of the Sai Parenteral’s IPO is to raise ₹60.55 crores, and the secondary objective is to:

1. Funding Working Capital Requirement of the Company
2. General corporate purposes

Sai Parenteral’s IPO Registrar

Bigshare Services Private Limited is the registrar for Sai Parenteral’s IPO, awaiting the allotment process and initiating refunds. For any queries regarding Bigshare Services Limited at ipo@bigshareonline.com or call +91-22-6263 8200.

Sai Parenteral’s IPO Review  

The Sai Parenteral’s IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Sai Parenteral’s Limited’s revenue increased by 5%, from ₹10.99 crore in March 2024 to ₹14.17 crore in March 2025. Moreover, the company’s PAT increased by 4% from ₹2.39 crore in March 2024 to ₹2.52 crore in March 2025.

Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for further ratings to gain a better understanding and will continue to post them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for Sai Parenteral’s IPO or not.

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Sai Parenteral’s IPO.

The P/E ratio of Sai Parenteral Limited’s shares is 72.19, and its Earnings Per Share (EPS) stands at 5.43. Thus, the Sai Parenteral’s IPO can deliver gains on its tentative listing date, 2nd April 2026. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Sai Parenteral Limited may change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!

FAQs on Sai Parenteral’s IPO

What is the GMP of the Sai Parenteral’s IPO?

Ans. Currently, on 24th March 2026, the Sai Parenteral’s IPO GMP (Grey Market Premium) stands at ₹0. This indicates that the estimated listing price could be ₹392.00 per share.

What is the issue price of the Sai Parenteral’s IPO?

Ans. The Sai Parenteral’s IPO price range is ₹372 to ₹392 per share.  Retail investors can apply for a minimum of 1 lot, each consisting of 38 shares, worth ₹14,896. Moreover, HNIs are required to bid for a minimum of 14 lots (532 shares) worth ₹2,08,544.

Who is the registrar of the Sai Parenteral’s IPO?

Bigshare Services Private Limited is the registrar for Sai Parenteral’s IPO, awaiting the allotment process and initiating refunds. For any queries regarding Bigshare Services Limited at ipo@bigshareonline.com or call +91-22-6263 8200.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Sai Parenteral’s IPO, download the Sai Parenteral’s IPO RHP and Sai Parenteral’s IPO DRHP. Conduct thorough research before investing in IPOs to minimise the risk of significant losses. You can also consult your financial advisor.

Recent Articles

Central Mine Planning & Design Institute IPO GMP Day 2

Speciality Medicines GMP Day 2

Innovision IPO Listing Today

Novus Loyalty IPO GMP Day 3

Novus Loyalty IPO Subscription Status Day 3

Rajputana Stainless IPO Listing Preview

Innovision IPO Listing Preview

Central Mine Planning & Design Institute IPO GMP Day 1